Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model

Catchpole, IanGermaschewski, VolkerHoh Kam, JaimieLundh von Leithner, PeterFord, SusannahGough, GeraldAdamson, PeterOverend, PhilipHilpert, JanLópez, Francisco J.Ng, Yin Shan EricCoffey, PeteJeffery, Glen2022-08-042013-06-14Catchpole, Ian, Volker Germaschewski, Jaimie Hoh Kam, Peter Lundh von Leithner, Susannah Ford, Gerald Gough, Peter Adamson et al. "Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model." PLoS ONE 8, no. 6 (2013): e65518. DOI: 10.1371/journal.pone.00655181932-6203https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37372937en-USMultidisciplinarySystemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse ModelJournal Article2018-06-1420132022-08-0410.1371/journal.pone.0065518